MKSAP 17 Audio Companion - Infectious Disease

• MKSAP_17_Audio_Companion_Infectious Disease.pdf
• 1-01 Introduction to Infectious Disease Section.m4a
• 1-02 Viral Meningitis.m4a
• 1-03 Diagnosis.m4a
• 1-04 Treatment.m4a
• 1-05 Session MCQ 01 Item 02 A 33-year-old Man Experiences a Generalized Tonic-Clonic Seizure.m4a
• 1-06 Bacterial Meningitis.m4a
• 1-07 Diagnosis.m4a
• 1-08 Management.m4a
• 1-09 Session MCQ 02 Item 04 A 42-year-old Woman with Fever, Chills, Redness, and Pain is Seen.m4a
• 1-10 Brain Abscess.m4a
• 1-11 Spinal Epidural Abscess.m4a
• 1-12 Cranial Subdural Empyema.m4a
• 1-13 Encephalitis.m4a
• 1-14 Herpes Simplex Encephalitis.m4a
• 1-15 Session 1 Key Points.m4a
• 1-16 Close to Session 1.m4a
• 2-01 Introduction to Session 2.m4a
• 2-02 Varicella-Zoster Virus Encephalitis.m4a
• 2-03 Neuroinvasive West Nile Virus and Autoimmune Encephalitis.m4a
• 2-04 Prion Diseases of the Central Nervous System.m4a
• 2-05 Creutzfeldt-Jakob Disease.m4a
• 2-06 Session MCQ 03 Item 05 A 40-year-old Woman is Seen for Fever, Night Sweats, and Weight Loss.m4a
• 2-07 Skin and Soft Tissue Infections.m4a
• 2-08 Community-Associated Methicillin-Resistant Staphylococcus Aureus.m4a
• 2-09 Necrotizing Fasciitis.m4a
• 2-10 Session MCQ 04 Item 06 A 19-year-old Woman is Hospitalized for a 3-Day History of Fever.m4a
• 2-11 Toxic Shock Syndrome.m4a
• 2-12 Animal and Human Bites.m4a
• 2-13 Diabetic Foot Infections.m4a
• 2-14 Session 2 Key Points.m4a
• 2-15 Close to Session 2.m4a
• 3-01 Introduction to Session 3.m4a
• 3-02 Community-Acquired Pneumonia.m4a
• 3-03 Diagnosis.m4a
• 3-04 Session MCQ 05 Item 07 A 52-year-old Woman with Severe Community-Acquired Pneumonia is Seen.m4a
• 3-05 Management.m4a
• 3-06 Antimicrobial Therapy.m4a
• 3-07 Complications.m4a
• 3-08 Follow-Up.m4a
• 3-09 Session MCQ 06 Item 09 A 28-year-old Woman is Admitted with Fever, Vomiting, and Change in Mental Status.m4a
• 3-10 Lyme Disease.m4a
• 3-11 Clinical Manifestations.m4a
• 3-12 Southern Tick-Associated Rash Illness and Babesiosis.m4a
• 3-13 Session 3 Key Points.m4a
• 3-14 Close to Session 3.m4a
• 4-01 Introduction to Session 4.m4a
• 4-02 Ehrlichiosis and Anaplasmosis.m4a
• 4-03 Rocky Mountain Spotted Fever.m4a
• 4-04 Urinary Tract Infections.m4a
• 4-05 Session MCQ 07 Item 12 A 33-year-old Man is Seen to Establish Ongoing Care.m4a
• 4-06 Diagnosis.m4a
• 4-07 Management of Asymptomatic Bacteriuria.m4a
• 4-08 Cystitis in Women.m4a
• 4-09 Acute Pyelonephritis.m4a
• 4-10 Recurrent Urinary Tract Infections in Women.m4a
• 4-11 Session MCQ 08 Item 14 A 30-year-old Woman is Evaluated for Increasing Pain.m4a
• 4-12 Acute Bacterial Prostatitis.m4a
• 4-13 Mycobacterium Tuberculosis Infection.m4a
• 4-14 Pathophysiology, Clinical Manifestations and Diagnostic Testing.m4a
• 4-15 Tuberculin Skin Test.m4a
• 4-16 Session 4 Key Points.m4a
• 4-17 Close to Session 4.m4a
• 5-01 Introduction to Session 5.m4a
• 5-03 Imaging, Culture and Additional Microbiologic Testing.m4a
• 5-04 Treatment.m4a
• 5-05 Tuberculosis Treatment Regimens.m4a
• 5-06 Session MCQ 09 Item 16 A 35-year-old Man with Concerns of a Possible HIV Exposure is Seen.m4a
• 5-07 Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.m4a
• 5-08 Prevention.m4a
• 5-09 Nontuberculous Mycobacterial Infections.m4a
• 5-10 Session MCQ 10 Item 19 A 42-year-old Woman is Evaluated for a 4 day Headache.m4a
• 5-11 Mycobacterium Avium Complex Infection.m4a
• 5-12 Mycobacterium Kansasii and Rapidly Growing Mycobacteria.m4a
• 5-13 Systemic Candidiasis.m4a
• 5-14 Treatment.m4a
• 5-15 Session 5 Key Points.m4a
• 5-16 Close to Session 5.m4a
• 6-01 Introduction to Session 6.m4a
• 6-02 Aspergillosis and Aspergilloma.m4a
• 6-03 Mucormycosis.m4a
• 6-04 Cryptococcosis.m4a
• 6-05 Blastomycosis.m4a
• 6-06 Session MCQ 11 Item 26 A 22-year-old Woman is Evaluated for Vaginal Discharge.m4a
• 6-07 Histoplasmosis and Coccidioidomycosis.m4a
• 6-08 Sporotrichosis and Exserohilum.m4a
• 6-09 Sexually Transmitted Infections.m4a
• 6-10 Neisseria Gonorrhoeae Infection.m4a
• 6-11 Session MCQ 12 Item 27 A 27-year-old Man is Hospitalized for Fever and Headaches.m4a
• 6-12 Cervicitis and Pelvic Inflammatory Disease.m4a
• 6-13 Urethritis, Epididymitis and Anorectal Infections.m4a
• 6-14 Treatment.m4a
• 6-15 Session 6 Key Points.m4a
• 6-16 Close to Session 6.m4a
• 7-01 Introduction to Session 7.m4a
• 7-02 Herpes Simplex Virus.m4a
• 7-03 Syphilis.m4a
• 7-04 Chancroid, Lymphogranuloma and Venereum Genital Warts.m4a
• 7-05 Osteomyelitis.m4a
• 7-06 Clinical Manifestations and Diagnosis.m4a
• 7-07 Laboratory Studies, Bone Biopsy and Treatment.m4a
• 7-08 Evaluation and Management of Diabetes-Associated Osteomyelitis.m4a
• 7-09 Evaluation and Management of Vertebral Osteomyelitis.m4a
• 7-10 Fever of Unknown Origin.m4a
• 7-11 Evaluation of FUO.m4a
• 7-12 Selective IgA Deficiency.m4a
• 7-13 Common Variable Immunodeficiency.m4a
• 7-14 Abnormalities in the Complement System.m4a
• 7-15 Anthrax.m4a
• 7-16 Smallpox and Plague.m4a
• 7-17 Session 7 Key Points.m4a
• 7-18 Close Session 7.m4a
• 8-01 Introduction to Session 8.m4a
• 8-02 Botulism and Tularemia.m4a
• 8-03 Viral Hemorrhagic Fever.m4a
• 8-04 Travel Medicine.m4a
• 8-05 Malaria.m4a
• 8-06 Typhoid Fever.m4a
• 8-07 Travelers Diarrhea.m4a
• 8-08 Dengue Fever.m4a
• 8-09 Hepatitis Virus Infection.m4a
• 8-10 Rickettsial Infection.m4a
• 8-11 Brucellosis.m4a
• 8-12 Other Important Diseases.m4a
• 8-13 Infectious Gastrointestinal Syndromes.m4a
• 8-14 Campylobacter Infection and Shigella Infection.m4a
• 8-15 Salmonella Infection.m4a
• 8-16 Escherichia Coli Infection.m4a
• 8-17 Yersinia Infection and Vibrio Infection.m4a
• 8-18 Session 8 Key Points.m4a
• 8-19 Close to Session 8.m4a
• 9-01 Introduction to Session 9.m4a
• 9-02 Clostridium Difficile Infection.m4a
• 9-03 Treatment Options for CDI.m4a
• 9-04 Viral Gastroenteritis and Parasitic Infections.m4a
• 9-05 Giardia Infection and Cryptosporidium Infection.m4a
• 9-06 Amebiasis and Cyclospora Infection.m4a
• 9-07 Antirejection Drugs in Transplant Recipients.m4a
• 9-08 Posttransplantation Infections.m4a
• 9-09 Viral and Bacterial Infections.m4a
• 9-10 Fungal Infections, Protozoa and Helminths.m4a
• 9-11 Prevention of Infections in Transplant Recipients.m4a
• 9-12 Health Care Associated Infections.m4a
• 9-13 Prevention.m4a
• 9-14 Catheter-Associated Urinary Tract Infections.m4a
• 9-15 Diagnosis.m4a
• 9-16 Treatment and Prevention.m4a
• 9-17 Session 9 Key Points.m4a
• 9-18 Close to Session 9.m4a
• 10-01 Introduction to Session 10.m4a
• 10-02 Surgical Site Infections.m4a
• 10-03 Diagnosis and Treatment.m4a
• 10-04 Prevention.m4a
• 10-05 Central Line Associated Bloodstream Infections.m4a
• 10-06 Prevention.m4a
• 10-07 Staphylococcus Aureus Bacteremia.m4a
• 10-08 Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia.m4a
• 10-09 Diagnosis, Treatment and Prevention.m4a
• 10-10 Hospital-Acquired Infections Caused by Antimicrobial-Resistant Organisms.m4a
• 10-11 Epidemiology and Prevention of HIV AIDS.m4a
• 10-12 Acute and Chronic HIV Infection and AIDS.m4a
• 10-13 Screening and Diagnosis.m4a
• 10-14 Session 10 Key Points.m4a
• 10-15 Close to Session 10.m4a
• 11-01 Introduction to Session 11.m4a
• 11-02 Initial Evaluation and Laboratory Testing.m4a
• 11-03 Immunization and Prophylaxis for Opportunistic Infections.m4a
• 11-04 Complications of HIV Infection in the Antiretroviral Therapy Era.m4a
• 11-05 Cardiovascular Disease.m4a
• 11-06 Immune Reconstitution Inflammatory Syndrome.m4a
• 11-07 Opportunistic Infections.m4a
• 11-08 When to Initiate Treatment for HIV Infection.m4a
• 11-09 Resistance Testing.m4a
• 11-10 Management of Pregnant Patients with HIV Infection.m4a
• 11-11 Postexposure Prophylaxis and Preexposure Prophylaxis.m4a
• 11-12 Session 11 Key Points.m4a
• 11-13 Close to Session 11.m4a
• 12-01 Introduction to Session 12.m4a
• 12-02 Influenza Viruses.m4a
• 12-03 Clinical Features and Evaluation.m4a
• 12-04 Novel Coronaviruses.m4a
• 12-05 Human Herpesvirus Infections.m4a
• 12-06 Herpes Simplex Viruses.m4a
• 12-07 Varicella-Zoster Virus.m4a
• 12-08 Management.m4a
• 12-09 Epstein-Barr Virus.m4a
• 12-10 Human Cytomegalovirus.m4a
• 12-11 Newer Antibacterial Drugs.m4a
• 12-13 Trimethoprim-Sulfamethoxazole and Polymyxins.m4a
• 12-14 Fosfomycin, Aminoglycosides and Rifamycins.m4a
• 12-15 Antimicrobial Stewardship.m4a
• 12-16 Outpatient Parenteral Antimicrobial Therapy.m4a
• 12-17 Session 12 Key Points.m4a
• 12-18 Close to Infectious Disease Section.m4a